Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.05
Real-Time Quote
As of Jul 28
 0.00 / 0.00%
Today’s Change
0.03
Today|||52-Week Range
0.23
-54.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues42.3K323.4K199.6K98.9K
 
 
 
 
 
Cost of Goods Sold56.9K211.1K104.9K169.4K
 
 
 
 
 
Depreciation And Amortization65.0K67.1K70.9K71.0K
 
 
 
 
 
 
Operating ExpensesGross Income-79.6K45.2K23.8K-141.5K
 
 
 
 
 
General Expenses1.4M4.6M4.7M2.0M
 
 
 
 
 
Research And Development114.0K542.5K1.4M352.8K
 
 
 
 
 
Total Operating Expenses1.5M4.9M4.9M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.5M-4.6M-4.7M-2.1M
 
 
 
 
 
Extraordinary Credit0.000.000.00421.3K
 
 
Extraordinary Charge0.000.000.00-146.0K
 
 
Interest Expense On Debt18.4K19.7K20.0K659.6K
 
 
 
 
 
Other Expenses-3.2K-1.6K-5.6K-4.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.5M-4.6M-4.7M-2.5M
 
 
 
 
 
Net Income-1.5M-4.6M-4.7M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.9M25.4M38.2M39.1M
 
 
 
 
 
Shares To Calculate EPS Diluted16.9M25.4M38.2M39.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.18-$0.12-$0.06
 
 
 
 
 
EPS Diluted-$0.09-$0.18-$0.12-$0.06